The Peptide Pulse — Episode 24: Peptide Regulations by State: What Every Provider and Patient Needs to Know Right Now

Right now, there is a peptide that is legal and prescribable medicine in one state, and just one mile across the border, it is a potential career-ending mistake.

This episode of The Peptide Pulse dives into the complexities of peptide medicine and how the same molecule can be treated completely differently depending on your location. I am Dr. Adam Boender and in this episode I am breaking down the regulatory map that every provider and patient needs to understand right now.

We are looking at critical insights from board notices, statutes, and federal filings that highlight the stark contrasts between states like Alabama and Louisiana. While one state is tightening restrictions, another is moving in the opposite direction. This inconsistency can leave providers and patients in a difficult position when it comes to liability, consent forms, and understanding what is actually legal in your jurisdiction.

If you are a clinician looking to implement peptides into your practice the right way, our team is here to help. Learn how to navigate this space effectively and protect your practice. Connect with us here: https://precisionpracticemastery.com/clinic/

As a consumer, knowing what you are putting into your body and finding providers who understand the legal landscape is essential. For providers, staying ahead means knowing your state regulations before they catch you off guard.

Subscribe to The Peptide Pulse for more conversations like this one and share this episode with fellow providers who need to know where the law stands in their state.

📍 Connect & Subscribe:

YouTube: @thepeptidepulse
 Instagram: @dradamboender
 Website: https://peptideresearcher.com/

🎧 Listen on: Spotify | Apple Podcasts | Buzzsprout

💬 Question for You:
Whats one Peptide or Peptide Stack your wanting to start trying in the new year? 
Drop it below 👇

Transcript

SPEAKER_00 0:15

Right now there's a peptide that is legal, prescribable medicine in one state, and just one mile across the border, it's the mistake that could possibly end a career. And if you practice like me on State Line Road in Kansas, uh, Missouri is literally right across the street because it was called State Line Road. So you got to be careful with that one. But here's the crazy thing: it's the same molecule, the same vial, same doctor, just a different zip code. You know, welcome to the most dangerous game in medicine nobody's talking about, where your address decide your treatment. I know it sounds messed up. And yes, I did a little Jeopardy voice thing, fun thing there. But you know, the truth is, it really is messed up. And so if you really want to understand like where this is going, make sure you watch this episode. This is the peptide pulse. I'm Dr. Adam Bounder, the peptide researcher, and today we are not decoding a molecule. We are decoding a map. That's right, a map. Because in 2026, the biggest variable in peptide medicine is not the science. It's actually the state line. In fact, it's even that way with a lot of other medications, but most people don't know it. But what's hot right now? Peptides. That's right. And this is the peptide pulse, so I'm bringing it to you. Today, I'm gonna show you four things that are on the public record right now: board notices, statutes, federal filings, uh receipts, all of these things. And by the end, you will understand why a favorable vote in Washington, literally this week, might not predict or even protect a single provider in the wrong state. So let's get into it. I don't know if you guys realize this. May 26, 2026, the Alabama Board of Medical Examiners did something most boards never do. And they actually put it in writing. This is what's crazy. So I'm gonna read this to you guys. The Alabama Board Notice, this is basically stating that your consent form is completely worthless. That's right. So if you're in Alabama, the Alabama Board of Medical Examiners prohibits physicians, PAs, uh CRNPs, CNMs, all of these people from prescribing to ministry, dispensing, or recommending non-FDA approved research grade peptides, and states that patient consent waiver forms labeling a product research grade are insufficient and not, and do not, sorry, I'm reading this, do not mitigate provider liability. So no delegating around it. I mean, that is what it actually says. So this ban covers the whole care team, the consent form that you thought protected you legally against it. But the truth is consent forms were never actually meant to legally protect you anyway, is to share what you're actually giving a patient, to share with them the risks, the benefits, and all of those things. So here's the thing no physician, no PA, no nurse practitioner may actually prescribe, administer, dispense, or even recommend a non-FDA approved research grade peptide. It's crazy. It's crazy. And and here's the line that honestly should stop every clinic owner cold. Your consent form. The one that you thought was, in a sense, your shield. The board says in writing, it is ineffective. It does not reduce your liability. Zero. But let's get into this for just a second. So think about that. You did the right paperwork. You had the patient sign it. And the board just told you that paperwork is actually, well, worth nothing. Turns out that the fine print is actually fiction. It's kind of crazy that when you utilize something to inform a patient, they're saying that no, no, no, that actually doesn't count as informing a patient of what's actually being given to them. So what are they gonna do? They're gonna change that now for high dose vitamin C, other modalities. I guess they can just choose what they want. And I know I'm being pretty straightforward and blunt with that, but it's kind of messed up. So now though, let's kind of pivot and shift here. If we drive west, same season, same country, it's a whole opposite universe. Louisiana passes an actual law. Okay, Senate Bill 253. So what does this say? Effective August 1st, 2026. And it says, You ready for this? You ready? Listen up.

unknown 4:57

Shh, come here.

SPEAKER_00 4:58

I'm gonna be quiet for a second because you gotta really focus in. It actually says the near exact opposite of Alabama. It bars the state's own licensing boards from prohibiting providers from prescribing peptides as long as they come from a properly registered pharmacy. So let me say this plainly. One state's board is banning it, the other state's legislature is actually protecting it. All happening within just months of each other. Now, real talk here. Like when you really think about this, Louisiana's law does not magically make it an unapproved peptide FDA approval. You know, federal rules obviously still exist, standard of care still exists, but the direction, the direction's night and day. Same molecule, two governments, two verdicts. It's crazy when you start looking at this stuff. It's it almost reminds me of like prohibition, and I'm not gonna get too deep into this, but like federal law versus state law. I mean, yes, you have your state board, state board of pharmacies, your state medical oversight, you have all of these things, but it's crazy to me the two polar opposites of what can be happening here. And you think of this truly, it's a it's a two-state story. So, you know, it's kind of like buckle up, here we go, because the map gets even messier. Ohio, all right? Ohio boards have suspended and pulled licenses over research-labeled vials sitting in a fridge. Possession, not a single injured patient required. Yeah, that's right. Nothing's happening to anybody. It's just because a vial says something. And the federal government, the Department of Justice, took one compounding operation for $1.79 million in forfeiture over peptides, including BPC 157. So that was when was that? That was that was a while back. But Fed's already turned peptide distribution case into a criminal conviction, nearly 1.8 million. Again, that was the Department of Justice over Taylor-made compounding LLC. So again, they're trying to make examples. It just needs to be done right. The other side of it, when you start looking at places like Washington, New Jersey, investigational use framing only. So again, they're looking at investigational use. Minnesota, dual enforcement, pharmacy and medical boards, and more than 40 state attorneys generals signed a joint letter to the FDA. So what are we looking at there? Washington, New Jersey frames peptides as investigational use only across the board, all of them. You do realize that, like, even some of your, I mean, Wingovey, these other GLPs, they're also peptides. I get it. There's, there's, uh, I mean, they have their uh legal names, they they have their their trademarks, they have all of these things. But the truth is peptides are peptides, they're short chain of amino acids that when come together, they're not biologics. But right now, which is crazy, is that the FDA is actually being sued by Eli Lilly to try to change the classification of peptides. Why do they want that? Because if they can change the classification of peptides, they can actually hold on to that classification based on a specific amino acid chain sequence and they can hold it for 10, 20 years. Hmm. Wonder if there's any money involved in that that they could make. Maybe just a little bit. So when we start looking at this, I mean, it's it's beyond. It really is. It's it's beyond Alabama, it's beyond Louisiana. States are landing all over the map. It's everywhere. And even the attorney generals are split screening the FDA. It's back and forth and back and forth. 50 states, 50 rule books, and most providers are reading exactly, well, none of them. None of them. So where do you stand? What are you doing? If you're a provider, if you're somebody that knows, and then here's the thing you know that that peptides work. You know that peptides can transform lives if used properly. Again, if used properly. Not black market, gray market, yes, and it's safe and it's it's traceable, and you know where you're getting this, and and you're making sure that you have a safe product. So here is where the whole country turns its eyes this week. All right, this week, July 23rd and 24th, the FDA's Pharmacy Compounding Advisory Committee, yes, the the PCAC. We've talked about this before in the in the last uh episode. So if you haven't watched that one, make sure you go back and watch that because it talks about really what's happening. But where the PCAC meets to weigh on whether a group of peptides should get a clearer federal lane. All right. And everybody is treating that vote like the finish line. The truth is it's not the finish line. Because even a favorable like federal vote does not override a state board. So if the FDA says maybe and Alabama says no, and Alabama, well, a no wins. Federal is the weather. Your state board is the ground you are standing on. And the ground is, well, where you get hurt. We've seen this movie before. It's happened. And no, I'm not talking about Twister. Okay, I know you're probably thinking about movie here, but a few years back, the same committee voted to add a compound that its only FDA staff had recommended against. The vote is advisory, not gospel. You just have to understand that. So when you're looking at that, the PCAC hearing, the twist, so what does the reachers say? FDA's pharmacy compounding advisory committee meets July 23rd to 4th. That's happening this week. Well, here in a couple days. And we're actually dropping this episode now because this information has to get out. Normally we wait, but this one's too important. Considering these peptides from BPC 157, KPV, TB500, MOTC on day one to the 503 book list, the vote is advisory, not binding. Again, I've said this many, many times. And it does not override state laws. That's what I think people don't fully understand. That like whether the FDA says yes or no, the state laws still have a holding and a bearing on all of this. FDA staff briefing documents reportedly recommended against adding them. And the FDA has said this. We don't want to add these. But again, the PCAC actually still has a stance and they can still say something. Even then, it still takes time. So this week's vote, again, is a recommendation. It's not law. States can actually create their own laws. So what does this mean for you? And if I'm talking fast, it's because I just I get excited and I go there. But let's slow down for a second. What does this mean for you? If you're a consumer, the question is no longer just, you know, is this peptide good? It is, what does this cost in my state? And does my provider actually know what's happening? A provider who cannot answer that is, well, kind of telling on themselves. They need to be able to understand what's happening on a state level, not just a government level. It's important. And honestly, if you're a provider, well, let me sit back real quick. As a consumer, I think one of the biggest things that you often be asking yourselves is you know, not can I get this for cheaper on a bro site over here or from my TikTok friend over here or the person that's driving me around in a cab. Because the truth is, all those things you should probably be running from. And not probably, you should be, because you don't know where anything's coming from. It could be a false COA, it could be, it could be junk, it could actually be deadly, quite honestly. And this episode is about truth. I think most of my episodes are about truth, but this one is like, I'm kind of hitting it hard because state to state it's different. But as a consumer, know what you are putting into your body. And what should you do? You should be seeking a provider that understands how these peptides work, fundamentally, how they work and how they're utilized within your body. Okay, that's vitally important. And if you're a provider, this is the moment. It's not the science, the map. Because the clinicians who survive the next 12 months will not be the ones with the best marketing. They will actually be the ones who read the board notices before the board reads them, honestly, their rights. And this is not here to scare you. It's to just to bring literally a spotlight onto something that needs to be revealed and understood. All right. This is exactly why, for the providers, like why I've created and why we have the creation of precision practice mastery. We have built something that honestly we've we've never handed out publicly. Um, I've never shared it here. Um, you know, really what we have created is a living state-by-state field guide. Honestly, it shows and it breaks down really where each state postures itself, the exact language that puts a target on a clinic's back. What is it that you're saying or not saying? We want to make sure that that target isn't on your back. We want to make sure that you understand things. The biggest thing in this industry is honestly knowing where legislation's going on a state level and a federal level so that you're not caught off guard. You know, and and why I've never shared this is because, well, number one, people have been asking for it for a while, and I've been holding on to it because I'm like, when do we release this? When do we do it? And I've been trying to keep it as current as possible because honestly, in this environment, current is the whole game. That's really what it is. We have to make sure that we're staying current and it shifts and changes, and it's been changing so much in the last honestly six months. So if you are a clinician who wants to stop guessing, this field guide, this kind of black book of the state guidance, I mean, it's for you. And and here's the truth under all of it this whole mess exists because everyone is trying to force peptides into a system that was actually never built for them. But the answer was never about more force. It was about a better signal, a better source, a better decision. Which is why my mission and my journey has been to really begin to help businesses, clinicians understand really the business of this. All right. Understanding what peptides do. Because in this business, your zip code might decide your medicine. It always has, quite honestly. It's just getting much brighter and a bigger spotlight on it now than it ever has. But your judgment decides your license. And that always has been the case too. Hey, if you guys found this information valuable, please subscribe to the peptide pulse because that's how we get this information out. Share this with one provider who still thinks the consent form is actually their force field, because it's not. And really, drop something that you'd like to learn more of. Uh, because I'd love to hear what you want, and I would love to bring that information to you. And a quick note this is education, not legal or medical advice, and it is all public record. Verify everything with your own counsel, with your own state board, because as you just learned, your state is the one that matters.